What is the optimal sequence for use of targeted agents in the treatment of renal cell carcinoma (RCC)?

Updated: Jun 08, 2020
  • Author: Kush Sachdeva, MD; Chief Editor: E Jason Abel, MD  more...
  • Print

These targeted agents have gained wide use as first-line, second-line, and subsequent lines of therapy. The optimal sequence of their use as targeted agents is not yet defined, however. 

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!